טוען...
Engineering HIV-Specific Immunity with Chimeric Antigen Receptors
HIV remains a highly important public health and clinical issue despite many recent advances in attempting to develop a cure, which has remained elusive for most people infected with HIV. HIV disease can be controlled with pharmacologic therapies; however, these treatments are expensive, may have se...
שמור ב:
| הוצא לאור ב: | AIDS Patient Care STDS |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Mary Ann Liebert, Inc.
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5144863/ https://ncbi.nlm.nih.gov/pubmed/27905838 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/apc.2016.0239 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|